Cargando…

Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease

AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from...

Descripción completa

Detalles Bibliográficos
Autores principales: Horvat, Natally, Tavares, Camila Carlos, Andrade, Adriana Ribas, Cabral, Julia Campos Simões, Leao-Filho, Hilton Muniz, Caiado, Angela Hissae Motoyama, Ueda, Serli Kiyomi Nakao, Leite, André Zonetti Arruda, Sipahi, Aytan Miranda, Rocha, Manoel Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143746/
https://www.ncbi.nlm.nih.gov/pubmed/28018107
http://dx.doi.org/10.3748/wjg.v22.i45.10002
_version_ 1782472991327649792
author Horvat, Natally
Tavares, Camila Carlos
Andrade, Adriana Ribas
Cabral, Julia Campos Simões
Leao-Filho, Hilton Muniz
Caiado, Angela Hissae Motoyama
Ueda, Serli Kiyomi Nakao
Leite, André Zonetti Arruda
Sipahi, Aytan Miranda
Rocha, Manoel Souza
author_facet Horvat, Natally
Tavares, Camila Carlos
Andrade, Adriana Ribas
Cabral, Julia Campos Simões
Leao-Filho, Hilton Muniz
Caiado, Angela Hissae Motoyama
Ueda, Serli Kiyomi Nakao
Leite, André Zonetti Arruda
Sipahi, Aytan Miranda
Rocha, Manoel Souza
author_sort Horvat, Natally
collection PubMed
description AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from January 2014 to June 2015. Patient inclusion criteria were confirmed inflammatory bowel disease (IBD) and FC collected < 4 mo after CTE without any change in clinical treatment or surgical treatment during this interval. The exclusion criterion was poor image quality. Two blinded abdominal radiologists, with 12 and 3 years of experience analyzed the CTE regarding localization (small bowel, colonic, both, or no disease detected); type of IBD (inflammatory, stenosing, fistulizing, > 1 pattern, or normal); and signs of active disease (present or absent). In 42 of 44 patients evaluated, routine CTE reports were made by one of the readers who re-evaluated the CTEs ≥ 6 mo later, to determine the intraobserver agreement. FC was considered a sign of disease activity when it was higher than 250 μg/g. RESULTS: Forty-four patients with IBD (38 with Crohn’s disease and 6 with ulcerative colitis) were included. There was a moderate interobserver agreement regarding localization of IBD (κ = 0.540), type of disease (κ = 0.410) and the presence of active signs in CTE (κ = 0.419). There was almost perfect intraobserver agreement regarding localization, type and signs of active disease in IBD. The κ values were 0.902, 0.937 and 0.830, respectively. After a consensus between both radiologists regarding inflammatory activity in CTE, we found that 24 (85.7%) of 28 patients who were classified with active disease had elevated FC, and six (37.5%) of 16 patients without inflammatory activity in CTE had elevated FC (P = 0.003). The correlation between elevated FC and the presence of active disease in CTE was significant (κ = 0.495, P = 0.001). CONCLUSION: We found almost perfect intraobserver and moderate interobserver agreement in the signs of active disease in CTE with concurrence of high FC levels.
format Online
Article
Text
id pubmed-5143746
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-51437462016-12-23 Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease Horvat, Natally Tavares, Camila Carlos Andrade, Adriana Ribas Cabral, Julia Campos Simões Leao-Filho, Hilton Muniz Caiado, Angela Hissae Motoyama Ueda, Serli Kiyomi Nakao Leite, André Zonetti Arruda Sipahi, Aytan Miranda Rocha, Manoel Souza World J Gastroenterol Retrospective Study AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from January 2014 to June 2015. Patient inclusion criteria were confirmed inflammatory bowel disease (IBD) and FC collected < 4 mo after CTE without any change in clinical treatment or surgical treatment during this interval. The exclusion criterion was poor image quality. Two blinded abdominal radiologists, with 12 and 3 years of experience analyzed the CTE regarding localization (small bowel, colonic, both, or no disease detected); type of IBD (inflammatory, stenosing, fistulizing, > 1 pattern, or normal); and signs of active disease (present or absent). In 42 of 44 patients evaluated, routine CTE reports were made by one of the readers who re-evaluated the CTEs ≥ 6 mo later, to determine the intraobserver agreement. FC was considered a sign of disease activity when it was higher than 250 μg/g. RESULTS: Forty-four patients with IBD (38 with Crohn’s disease and 6 with ulcerative colitis) were included. There was a moderate interobserver agreement regarding localization of IBD (κ = 0.540), type of disease (κ = 0.410) and the presence of active signs in CTE (κ = 0.419). There was almost perfect intraobserver agreement regarding localization, type and signs of active disease in IBD. The κ values were 0.902, 0.937 and 0.830, respectively. After a consensus between both radiologists regarding inflammatory activity in CTE, we found that 24 (85.7%) of 28 patients who were classified with active disease had elevated FC, and six (37.5%) of 16 patients without inflammatory activity in CTE had elevated FC (P = 0.003). The correlation between elevated FC and the presence of active disease in CTE was significant (κ = 0.495, P = 0.001). CONCLUSION: We found almost perfect intraobserver and moderate interobserver agreement in the signs of active disease in CTE with concurrence of high FC levels. Baishideng Publishing Group Inc 2016-12-07 2016-12-07 /pmc/articles/PMC5143746/ /pubmed/28018107 http://dx.doi.org/10.3748/wjg.v22.i45.10002 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Horvat, Natally
Tavares, Camila Carlos
Andrade, Adriana Ribas
Cabral, Julia Campos Simões
Leao-Filho, Hilton Muniz
Caiado, Angela Hissae Motoyama
Ueda, Serli Kiyomi Nakao
Leite, André Zonetti Arruda
Sipahi, Aytan Miranda
Rocha, Manoel Souza
Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title_full Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title_fullStr Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title_full_unstemmed Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title_short Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
title_sort inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143746/
https://www.ncbi.nlm.nih.gov/pubmed/28018107
http://dx.doi.org/10.3748/wjg.v22.i45.10002
work_keys_str_mv AT horvatnatally interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT tavarescamilacarlos interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT andradeadrianaribas interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT cabraljuliacampossimoes interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT leaofilhohiltonmuniz interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT caiadoangelahissaemotoyama interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT uedaserlikiyominakao interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT leiteandrezonettiarruda interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT sipahiaytanmiranda interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease
AT rochamanoelsouza interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease